Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-20

Clinical Trial Update: Study of the Long Term Efficacy of Recombinant Hepatitis B Vaccine in Nile Delta of Egypt

View source ↗

Summary

This clinical trial update describes the long-term efficacy study of a recombinant hepatitis B vaccine conducted in the Nile Delta region of Egypt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant hepatitis B vaccine (hepatitis B vaccine, recombinant)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Hepatitis B Vaccines | Status: UNKNOWN